ETAMSYLATE 250mg. IP + TRANEXAMIC ACID 250mg. IP

An antihemorrhagic agent designed to treat heavy or prolonged bleeding. A potent hemostatic agent for both acute and long-term treatment of heavy menstrual bleeding. (Amani Meaidi, 2021) Enhances platelet adhesiveness and restores capillary resistance. (Ricardo P Garay, 2006) A beneficial drug in a wide range of hemorrhagic conditions. (C J Dunn, 1999) Produces statistically significant reductions in blood loss in dysfunctional uterine bleeding individuals. (G Chamberlain, 1991) A well-tolerated drug, particularly useful in dysfunctional uterine bleeding. (Ricardo P Garay, 2006) More effective at reducing menstrual blood loss than mefenamic acid, flurbiprofen, and oral luteal phase norethisterone. (Keri Wellington, 2003) Ameliorates the health-related quality of life in women with heavy menstrual bleeding. (Mary Ann Lumsden, 2011) A safe and highly effective treatment of heavy menstrual bleeding. (P. Yamini Shoba Vani, 2018) A potential therapeutic choice for postpartum hemorrhage, menorrhagia, trauma-associated hemorrhage, and surgical bleeding. (Johnny Cai, 2020)